Not long after SARS-CoV-2 was first identified in December 2019 as the cause of an alarming cluster of severe pneumonia cases in central China, the U.S. Centers for Disease Control and Prevention ...
When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...
CLIFTON, N.J., Jan. 15, 2025 /PRNewswire/ -- CS Analytical Laboratory, the world's only FDA regulated contract laboratory exclusively dedicated to providing regulatory solutions and qualification ...
DURHAM, N.C., Aug. 23, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the ...
Akul Gunukula/DAILY. Buy this photo. The University of Michigan no longer operates any Biosafety Level 3 laboratories, following the U.S. Centers for Disease Control and Prevention’s changes to ...
In Pakistan, many institutes work using BSL-1 and BSL-2 level facilities. The National Institute of Health, Islamabad has been working at BSL-2+ and is constructing BSL-3 facilities. BSL-3 facilities ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first emerged in December 2019 in Wuhan, China, and rapidly spread to other countries, causing an unprecedented global pandemic. Today, the ...
All projects involving biological agents must be reviewed and approved by the Institutional Biosafety Committee (IBC) prior to commencement of the work (see Scope on page 1-1 for a listing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results